M4 · EVIDENCE SYNTHESIS

Reading the whole story at a glance

You've already seen three of these charts in this module. Now learn to read one cold — because the forest plot is the single most common picture in all of HTA, and every mark on it means something.

You've met the forest plot three times now — weighing studies, watching a diamond move, toggling between two models. Each time, it carried the whole analysis in one picture.

But we never stopped to read it properly. And in HTA you'll read hundreds of them — it's the standard way every meta-analysis reports itself, in every dossier, every guideline, every appraisal. The people who are fluent don't study a forest plot. They glance at it and the whole story falls out: which trials, how much each counts, whether they agree, what the combined answer is, and whether it's significant.

That fluency is just knowing what every mark means. By the end of this lesson, you'll have it.

One picture, the whole analysis

A forest plot looks busy, but it's built from just a handful of elements, and none of them is decoration. Every square, every line, every position is carrying a specific piece of information.

Here's the whole vocabulary, in one sentence: each row is a study, drawn as a square at its effect (left or right) with whiskers showing its confidence interval; the square's size is its weight; and at the bottom, a diamond shows the pooled result — its position the combined effect, its width the combined uncertainty. A vertical line marks "no effect."

That's it. Six things. Learn to see each one and you can read any forest plot ever printed. So let's take one apart — literally.

Take it apart

Below is a forest plot from a real-style meta-analysis: five trials of a treatment, measured as a risk ratio — a value below 1 means the treatment reduces risk. Tap each part to find out what it's telling you — work through all five.

StudyRR (95% CI) WeightA0.70 (0.52–0.94) 43.8%B0.85 (0.52–1.39) 15.8%C0.60 (0.33–1.08) 10.9%D0.75 (0.51–1.11) 24.6%E0.90 (0.37–2.17) 4.9%Pooled0.73 (0.60–0.89)0.30.50.71.01.52.0◄ Favours treatmentFavours control ►

Risk ratio scale. Null line (no effect) at RR = 1. Squares: study effect and weight. Whiskers: 95% CI. Diamond: pooled result.

The trap: size is not effect

One misreading catches almost everyone, so let's kill it now.

A bigger square does not mean a bigger effect. The square's size is its weight — precision, driven by sample size. The effect is the square's horizontal position, not its area. These are two completely separate dimensions of the same square: where it sits (effect) and how big it is (weight).

Look at the plot you just took apart: Study A has the biggest square, but Study C sits furthest from the null line. A is the heaviest, but C found the biggest effect. Size and position are telling you two different things about two different studies — read them separately.

So the most misread pattern is a large square sitting right on the null line: a big, precise, heavily-weighted study showing no effect at all. Position is what. Size is how much it counts. Keep them apart.

Where's "no effect"?

One more thing to check before you trust your reading of any forest plot: where is the null line? Because it isn't always at zero.

It depends on what the effect is measured as — and you know both kinds from Module 3:

Get this wrong and you'll misread every significance call on the chart. A diamond sitting at 0.73 on a risk-ratio plot is a 27% reduction and — since its whole interval stays left of 1 — significant; but only if you know the line to beat is 1, not 0. Always find the null line first, then read everything relative to it.

Now read one

Using this plot (risk ratio, null line at 1), answer four questions by reading the chart.

StudyRR (95% CI) WeightA0.70 (0.52–0.94) 43.8%B0.85 (0.52–1.39) 15.8%C0.60 (0.33–1.08) 10.9%D0.75 (0.51–1.11) 24.6%E0.90 (0.37–2.17) 4.9%Pooled0.73 (0.60–0.89)0.30.50.71.01.52.0◄ Favours treatmentFavours control ►

Q1. Which study carries the most weight?

Q2. Which study is the least precise?

Q3. Is the pooled result statistically significant?

Q4. Do the studies broadly agree?

The scatter tells a story

That last question was bigger than it looked. How spread out the squares are is heterogeneity, read by eye.

When the squares cluster tightly around a shared value — like the plot you just read — the trials broadly agree, and the fixed-effect world from the last lesson looks credible. When they're flung across the axis, some far left, some far right, the trials genuinely disagree — you're likely in the random-effects world, and a single pooled number hides real conflict.

So before you even reach for a statistic, a forest plot tells you which world you're in — just from the shape of the scatter. You can feel the heterogeneity before you measure it. And measuring it — turning that visual scatter into a single number, , so the judgement isn't just eyeballing — is exactly where the next lesson goes.

Why this matters for HTA

Every meta-analysis in every dossier arrives as a forest plot. Reading it fluently — and sceptically — is a core appraisal skill, and most of what you need is on the chart if you know where to look.

"The forest plot doesn't just report the answer — it shows you how much to trust it. Learn to read the whole picture, and the summary line can never fool you."

The other chair. Before a committee sees your meta-analysis, read your own forest plot the way they will: find the heaviest study, the outlier, and the study whose removal changes the verdict. If you know which square they'll attack, you can bring the answer — or fix the analysis — first.

Reading a forest plot, in one breath

"Fluent readers don't study a forest plot — they glance, and the whole story falls out: who counts, whether they agree, and how far to trust the answer."

That completes the picture this module has been building. You can find the studies, count them, search for them, judge each one's risk of bias, combine them by weight, choose the right model, and now read the result at a glance. One thing still hangs over the forest plot, though: that scatter. We've been eyeballing whether studies "agree" — but eyeballing isn't a method. The next lesson makes it one, with a number for heterogeneity (I²) and a way to spot when the studies you've pooled shouldn't have been pooled at all.